Daily Anesthesiology Research Analysis
Three studies stand out in anesthesiology and perioperative medicine: a large meta-analysis shows remote ischemic preconditioning (RIPC) reduces mortality and stroke after noncardiac surgery; an AI RAG system using international guidelines outperforms humans in preoperative fitness assessments; and a meta-analysis suggests sugammadex reduces early perioperative neurocognitive dysfunction versus neostigmine.
Summary
Three studies stand out in anesthesiology and perioperative medicine: a large meta-analysis shows remote ischemic preconditioning (RIPC) reduces mortality and stroke after noncardiac surgery; an AI RAG system using international guidelines outperforms humans in preoperative fitness assessments; and a meta-analysis suggests sugammadex reduces early perioperative neurocognitive dysfunction versus neostigmine.
Research Themes
- Perioperative organ protection and outcomes
- AI decision support for preoperative assessment
- Neurocognitive outcomes and neuromuscular blockade reversal
Selected Articles
1. Remote ischaemic preconditioning and survival in noncardiac surgery: a meta-analysis of randomised trials.
Across 72 RCTs in noncardiac surgery, RIPC was associated with lower mortality (RR 0.74) and reduced postoperative stroke and shorter hospital stay versus controls. These findings support RIPC as a low-cost, noninvasive strategy for perioperative organ protection and justify a definitive multicenter RCT.
Impact: First meta-analysis to link RIPC with survival benefit in noncardiac surgery with consistent secondary improvements. It may shift practice toward routine perioperative RIPC protocols.
Clinical Implications: Consider implementing standardized RIPC protocols in high-risk noncardiac surgeries as an adjunct to enhance organ protection, while awaiting confirmatory multicenter trials.
Key Findings
- Meta-analysis of 72 RCTs (n=7457) in noncardiac surgery settings.
- Mortality reduced with RIPC versus control (88/2122 vs 102/1767; RR 0.74, 95% CI 0.57–0.98; P=0.03).
- Bayesian analysis indicated a high probability of mortality benefit (RR<1).
- Secondary outcomes showed reduced postoperative stroke and shorter hospital stay.
Methodological Strengths
- Comprehensive meta-analysis of randomized trials with PROSPERO registration (CRD42024588358).
- Use of both frequentist random-effects and Bayesian analyses.
Limitations
- Mortality data available in only 28 of 72 RCTs; potential reporting bias.
- Heterogeneity in RIPC protocols and surgical populations; possible small-study effects.
Future Directions: A large, pragmatic multicenter RCT with standardized RIPC protocols, patient-centered outcomes, and cost-effectiveness analysis is warranted.
BACKGROUND: Remote ischaemic preconditioning (RIPC) is an intervention involving brief periods of limb ischaemia to protect remote organs from subsequent ischaemic injury. Although evidence exists on the beneficial effects of RIPC on biomarkers, its effect on survival is unknown. We performed a meta-analysis of randomised controlled trials (RCTs) to evaluate whether RIPC improves survival in noncardiac surgery. METHODS: We searched several electronic databases for randomised trials comparing RIPC vs a control group in adult noncardiac surgical settings. The primary outcome was mortality at the longest follow-up available. We conducted a random-effects meta-analysis to calculate the risk ratio (RR) and 95% confidence intervals (CIs). Bayesian statistics were used to estimate the probability of mortality benefit (RR <1). RESULTS: We identified 72 RCTs, which included 7457 subjects. Mortality was reported in 28 RCTs and was lower in the RIPC group compared with the control group (88/2122 [4.1%] vs 102/1767 [5.8%]; RR 0.74, 95% CI 0.57-0.98, P=0.03; I
2. Retrieval augmented generation for 10 large language models and its generalizability in assessing medical fitness.
In 14 standardized preoperative scenarios using 58 guidelines, GPT-4 with RAG produced 96.4% accuracy—significantly outperforming human responses—with no hallucinations and faster turnaround. Results suggest guideline-grounded LLMs can support safe, efficient preoperative fitness assessments.
Impact: Demonstrates clinically relevant, guideline-grounded AI outperforming humans in perioperative decision tasks, addressing consistency and hallucination risks central to clinical adoption.
Clinical Implications: Hospitals could pilot RAG-based preoperative decision support to standardize risk triage and instructions, with governance for data security, audit trails, clinician oversight, and local guideline integration.
Key Findings
- Evaluated 10 LLMs with RAG across 14 clinical preoperative scenarios using 58 guidelines.
- Generated 3234 model responses versus 448 human answers; GPT-4 RAG achieved 96.4% accuracy vs. 86.6% for humans (p=0.016).
- No hallucinations were observed; AI outputs were more consistent and delivered within ~20 seconds.
Methodological Strengths
- Head-to-head benchmarking across multiple LLMs with both local and international guidelines.
- Large response corpus (n=3234) with statistical comparison to human performance and safety checks for hallucinations.
Limitations
- Scenario-based evaluation rather than real-world patient care; external validity requires clinical implementation studies.
- Performance may depend on guideline quality/coverage and prompt engineering; generalizability beyond included guidelines is uncertain.
Future Directions: Prospective clinical trials testing AI-RAG-assisted preoperative clinics, impact on cancellations, safety events, workflow efficiency, and cost-effectiveness, with fairness and governance evaluation.
Large Language Models (LLMs) hold promise for medical applications but often lack domain-specific expertise. Retrieval Augmented Generation (RAG) enables customization by integrating specialized knowledge. This study assessed the accuracy, consistency, and safety of LLM-RAG models in determining surgical fitness and delivering preoperative instructions using 35 local and 23 international guidelines. Ten LLMs (e.g., GPT3.5, GPT4, GPT4o, Gemini, Llama2, and Llama3, Claude) were tested across 14 clinical scenarios. A total of 3234 responses were generated and compared to 448 human-generated answers. The GPT4 LLM-RAG model with international guidelines generated answers within 20 s and achieved the highest accuracy, which was significantly better than human-generated responses (96.4% vs. 86.6%, p = 0.016). Additionally, the model exhibited an absence of hallucinations and produced more consistent output than humans. This study underscores the potential of GPT-4-based LLM-RAG models to deliver highly accurate, efficient, and consistent preoperative assessments.
3. The effect of neuromuscular blocking reversal agents on perioperative neurocognitive function after general anaesthesia: a systematic review and meta-analysis.
Across 10 RCTs (n=1705), sugammadex reduced early PND versus neostigmine (RR 0.67) without increasing adverse events, while accelerating TOF recovery. This suggests a neurocognitive advantage to sugammadex in the immediate postoperative period.
Impact: Addresses a clinically relevant and common outcome—PND—providing comparative evidence that may influence routine reversal agent selection.
Clinical Implications: When risk of early PND is a concern (e.g., older adults, cognitive vulnerability), clinicians may favor sugammadex over neostigmine, considering cost and availability.
Key Findings
- Systematic review and meta-analysis of 10 RCTs including 1705 patients under general anesthesia.
- Sugammadex reduced early postoperative PND compared with neostigmine (RR 0.67; 95% CI 0.48–0.94).
- No increase in adverse events (e.g., PONV, mortality); faster recovery to TOF ≥0.9.
Methodological Strengths
- Pre-registered protocol (PROSPERO CRD42024520287) with GRADE assessment.
- Focused RCT-only evidence base with predefined outcomes.
Limitations
- Heterogeneity in PND definitions and neurocognitive tests; follow-up restricted to ≤7 days.
- Potential publication bias; limited trials directly comparing the same regimens.
Future Directions: Longer-term RCTs assessing sustained neurocognitive outcomes, cost-effectiveness, and subgroup effects (e.g., frailty, baseline cognitive impairment).
BACKGROUND: Perioperative neurocognitive dysfunction (PND) is influenced by various perioperative factors. Recent studies suggest that neuromuscular blocking reversal agents (NMBRs) may impact on PND. However, the results have been inconsistent. Therefore, we aimed to compare the effects of perioperative NMBRs on PND through this systematic review and meta-analysis. METHODS: We searched PubMed, CENTRAL, Embase, Web of Science, Scopus, and China Biology Medicine from their inception until May 2024. Two reviewers independently identified randomized controlled trials (RCTs) that compared the perioperative use of NMBRs with either a placebo or other NMBRs in patients undergoing general anaesthesia. We assessed the certainty of the evidence using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology. The primary outcome was the incidence of PND within 7 days following surgery, while the secondary outcomes included the time required to achieve a Train-of-Four ratio (TOF) ≥ 0.9 after administration of NMBRs, length of stay (LOS) in both the post-anaesthesia care unit (PACU) and the hospital, as well as the risk of adverse events (i.e. postoperative nausea and vomiting (PONV) and mortality). RESULTS: A total of 10 randomized controlled trials involving 1705 patients compared the effects of NMBRs on PND. Neostigmine and sugammadex are the most commonly used NMBRs in clinical anaesthesia practice. In the primary analyses of all regimens, sugammadex significantly reduced the incidence of PND compared to neostigmine (risk ratio [RR] 0.67; 95% confidence interval [CI]:0.48-0.94; I CONCLUSIONS: This meta-analysis demonstrated that the use of sugammadex was associated with improved early perioperative neurocognitive function compared to neostigmine when used to reverse neuromuscular blockade, without an increase in the incidence of adverse events. SYSTEMATIC REVIEW PROTOCOL: PROSPERO CRD42024520287.